| J3245 | Injection, tildrakizumab, 1 mg | 12,500 | $110 | $1.4M |
| Q4190 | Artacent ac, per square centimeter (add-on, list separately in addition to primary procedure) | 1,040 | $400 | $414.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 2,950 | $60 | $185.7K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 2,860 | $60 | $160.2K |
| Q4169 | Artacent wound, per square centimeter (add-on, list separately in addition to primary procedure) | 460 | $320 | $146.3K |
| 17000 | The provider destroys a premalignant lesion using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of the first or only lesion. | 1,500 | $40 | $52.6K |
| 17004 | The provider destroys 15 or more premalignant lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. | 280 | $130 | $36.9K |
| 15271 | The provider uses a skin substitute, such as an allograft or xenograft, to cover wounds on the patient’s trunk, arms, and/or legs up to an area of 100 cm2. This code covers up to the first 25 cm2. | 240 | $110 | $26.6K |
| 11302 | The provider shaves off a single epidermal or dermal lesion of 1.1 to 2.0 cm in diameter from the skin of the trunk, arms, or legs. | 280 | $90 | $25.2K |
| 17110 | The provider destroys benign lesions using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of one to 14 lesions other than skin tags or… | 390 | $60 | $25.2K |